North America Virtual Clinical Trials Market

North America Virtual Clinical Trials Market size was valued at USD 5.7 billion in 2025 and is forecast to grow from USD 6.0 billion in 2026 to reach USD 7.7 billion by 2031, at a CAGR of 6.2%.

Description

The North America Virtual Clinical Trials Market size was valued at USD 5.7 billion in 2025 and is forecast to grow from USD 6.0 billion in 2026 to reach USD 7.7 billion by 2031, at a CAGR of 6.2%. Virtual clinical trials, also known as decentralized clinical trials, use telehealth visits, remote patient monitoring, electronic informed consent, and direct-to-patient drug shipment to conduct all or part of a clinical study outside traditional investigator sites, reducing participant burden while broadening geographic access to trial enrollment. The market sits at the intersection of digital health, clinical research operations, and patient-centered trial design, making it one of the most closely watched enabling technologies across the regional biopharmaceutical-development value chain.

Demand for virtual clinical trial platforms remains anchored by sponsors' continued shift toward hybrid and fully remote trial models as standard rather than contingency options, rising R&D investment among pharmaceutical and biotechnology companies, and growing regulatory support for decentralized trial components across the United States, Canada, and Mexico. Beyond interventional drug trials, virtual clinical trial technology continues to enable applications in real-world-evidence studies, post-market surveillance, and expanded-access programs that require flexible, patient-centric data collection. Rising healthcare digitization, expanding cloud-based trial-management infrastructure, and continued investment in AI-enabled patient-recruitment tools are sustaining consumption even as the region transitions toward more diversified, technology-integrated trial-execution models.

Table of Contents

  • Product Overview

    1. Market Definition

    2. Scope of the Market

      1. Markets Covered

      2. Years Considered for Study

      3. Key Market Segmentations

  • Research Methodology

    1. Objective of the Study

    2. Baseline Methodology

    3. Key Industry Partners

    4. Major Association and Secondary Sources

    5. Forecasting Methodology

    6. Data Triangulation & Validation

    7. Assumptions and Limitations

  • Executive Summary

    1. Overview of the Market

    2. Overview of Key Market Segmentations

    3. Overview of Key Market Players

    4. Overview of Key Regions/Countries

    5. Overview of Market Drivers, Challenges, Trends

  • Voice of Customer

  • North America Virtual Clinical Trials Market Outlook

    1. Market Size & Forecast

      1. By Value

    2. Market Share & Forecast

      1. By Component (Software, Services)

      2. By Application (Oncology, Neurology, Cardiovascular Diseases, Infectious Diseases, Others)

      3. By End User (Pharmaceutical & Biotechnology Companies, Medical Device Manufacturers, Contract Research Organizations, Others)

      4. By Country

      5. By Company (2025)

    3. Product Map

  • United States Virtual Clinical Trials Market Outlook

    1. Market Size & Forecast

      1. By Value

    2. Market Share & Forecast

      1. By Component

      2. By Application

      3. By End User

  • Canada Virtual Clinical Trials Market Outlook

    1. Market Size & Forecast

      1. By Value

    2. Market Share & Forecast

      1. By Component

      2. By Application

      3. By End User

  • Mexico Virtual Clinical Trials Market Outlook

    1. Market Size & Forecast

      1. By Value

    2. Market Share & Forecast

      1. By Component

      2. By Application

      3. By End User

  • Market Dynamics

    1. Drivers

    2. Challenges

  • Market Trends & Developments

    1. Merger & Acquisition (If Any)

    2. Product Launches (If Any)

    3. Recent Developments

  • North America Virtual Clinical Trials Market: SWOT Analysis

  • Porter's Five Forces Analysis

    1. Competition in the Industry

    2. Potential of New Entrants

    3. Power of Suppliers

    4. Power of Customers

    5. Threat of Substitute Products

  • Competitive Landscape

    1. IQVIA Inc.

      1. Business Overview

      2. Products & Services

      3. Recent Developments

      4. Key Personnel

      5. SWOT Analysis

    2. Medable, Inc.

    3. Signant Health

    4. Parexel International Corporation

    5. ICON plc

    6. Thermo Fisher Scientific Inc. (PPD)

    7. Oracle Corporation

    8. Veeva Systems Inc.

    9. Huma Therapeutics Limited

    10. Anju Software, Inc.

  • Strategic Recommendations

  • About Us & Disclaimer

    • Methodology